CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

March 31, 2023 · earnings

NRXP earnings: a negative outcome, -10.6%

On March 31, 2023, NRX Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.6% in the window around the event. It had already run -22.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$7.37
1d before
$6.59
Event day
$6.59
1d after
$5.50
5d after

Pre-catalyst setup

-22.0%
30-day run-up
7830%
30-day volatility
1.7×
volume spike